Reckitt Benckiser first-quarter sales miss estimates

Reckitt Benckiser first-quarter sales miss estimates
FILE PHOTO: Products produced by Reckitt Benckiser; Vanish, Finish, Dettol and Harpic, are seen in London, Britain February 12, 2008. REUTERS/Stephen Hird/File Photo -
Stephen Hird(Reuters)
Text size Aa Aa

LONDON (Reuters) - Reckitt Benckiser Group reported lower-than-expected first-quarter sales on Thursday, citing a slow start to the year in its health business.

The maker of Strepsils and Mucinex cold medicine and Lysol cleaners said like-for-like sales rose 1 percent in the first quarter. Analysts on average were expecting sales on that basis to rise 1.8 percent, according to a company-supplied consensus.

The company called out an unusually weak cold and flu season in the United States and several European markets.

Net revenue was 3.16 billion pounds, missing analysts' estimate of 3.19 billion pounds.

(Reporting by Martinne Geller; editing by Jason Neely)

euronews provides breaking news articles from reuters as a service to its readers, but does not edit the articles it publishes. Articles appear on for a limited time.